Statera Biopharma, Inc. Stock-Based Compensation
Statera Biopharma, Inc. reported Stock-Based Compensation of -$900.78 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-11-14
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-09-30 was -$287.64K, a 124.41% decline year-over-year.
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-06-30 was -$1.07M, a 154.29% decline year-over-year.
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-03-31 was $452.54K, a 75.08% decline year-over-year.
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-12-31 was $1.10M, a 61.01% decline year-over-year.
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $6.06M, a 124.45% increase from fiscal 2020.
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $2.70M.
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for fiscal 2011 was $4.04M, a 39.29% decline from fiscal 2010.
- Statera Biopharma, Inc. share-based payment arrangement, noncash expense for fiscal 2010 was $6.66M, a 78.58% increase from fiscal 2009.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-09-30 | -$287.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.35M derived: sum of 2 quarters · filed 2022-11-14 | -$900.78K 10-Q · filed 2022-11-14 | $201.14K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2022-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | -$613.15K 10-Q · filed 2022-10-28 | $488.77K derived: sum of 3 quarters · filed 2022-10-28 | $1.67M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2022-03-31 | $452.54K 10-Q · filed 2022-10-21 | $1.55M derived: sum of 2 quarters · filed 2022-10-21 | $2.73M derived: sum of 3 quarters · filed 2022-11-14 | $4.70M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $2.28M derived: sum of 2 quarters · filed 2022-11-14 | $4.24M derived: sum of 3 quarters · filed 2022-11-14 | $6.06M 10-K · filed 2022-10-06 | ||
| 2021-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.14M derived: sum of 2 quarters · filed 2022-11-14 | $4.96M 10-Q · filed 2022-11-14 | $7.78M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | $3.78M 10-Q · filed 2022-10-28 | $6.61M derived: sum of 3 quarters · filed 2022-10-28 | |||
| 2021-03-31 | $1.82M 10-Q · filed 2022-10-21 | $4.64M derived: sum of 2 quarters · filed 2022-10-21 | ||||
| 2020-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $2.70M 10-K · filed 2022-10-06 | $13.50K 10-K · filed 2021-03-22 | |||
| 2020-09-30 | -$126.15K 10-Q · filed 2021-11-15 | $13.50K 10-Q · filed 2020-11-16 | ||||
| 2013-03-31 | $60.00K 10-Q · filed 2013-05-09 | |||||
| 2012-09-30 | -$27.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $465.00K derived: sum of 2 quarters · filed 2012-11-09 | $739.50K 10-Q · filed 2012-11-09 | $3.37M derived: sum of 4 quarters · filed 2013-05-09 | ||
| 2012-06-30 | $492.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $767.29K 10-Q · filed 2012-08-09 | $3.40M derived: sum of 3 quarters · filed 2013-05-09 | $3.13M derived: sum of 4 quarters · filed 2013-05-09 | ||
| 2012-03-31 | $274.50K 10-Q · filed 2013-05-09 | $2.91M derived: sum of 2 quarters · filed 2013-05-09 | $2.63M derived: sum of 3 quarters · filed 2013-05-09 | |||
| 2011-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13 | $2.36M derived: sum of 2 quarters · filed 2012-11-09 | $4.04M 10-K · filed 2012-03-13 | |||
| 2011-09-30 | -$275.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.41M 10-Q · filed 2012-11-09 | ||||
| 2011-06-30 | $1.69M 10-Q · filed 2012-08-09 | |||||
| 2010-12-31 | $6.66M 10-K · filed 2012-03-13 | |||||
| 2009-12-31 | $3.73M 10-K · filed 2012-03-13 |